Drugs / AbGn-107
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02908451 | Apr 2017 → Feb 2021 | biliary tract cancer, colorectal cancer, gastric cancer, malignant pancreatic neoplasm | AbGenomics B.V Taiwan Branch | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AbGn-107 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02908451 ↗ |
| Route | Intravenous | “via intravenous infusion” NCT02908451 ↗ |